CT Logo

New Made-in-India pharmaceutical packaging platform renews the founders’ 35-year legacy with a global portfolio of tubular glass and Ready-to-Use solutions

The Dadachanji Group has launched Kaisha Pharma, a new global pharmaceutical packaging platform established to serve pharmaceutical and biotechnology companies worldwide.

The launch marks a renewed chapter in the founders’ 35-year association with primary pharmaceutical glass packaging. As part of a broader multi-million-euro commitment, the Group has made an initial investment of €45 million to expand Kaisha Pharma’s infrastructure, production capacity and operational capabilities.

Built in India with global ambitions, the company will focus on delivering quality, consistency, technical innovation and scientific support to pharmaceutical manufacturers across international markets.

Comprehensive Pharmaceutical Glass Portfolio

Kaisha Pharma enters the market with a complete portfolio of tubular glass packaging products, including ampoules, vials, prefilled syringes and cartridges.

The company will also offer advanced Ready-to-Use platforms for vials, prefilled syringes and cartridges. These solutions are designed to support safer, faster and more efficient fill-finish operations while meeting the stringent quality requirements of global pharmaceutical manufacturers.

Beyond conventional packaging formats, Kaisha Pharma is developing specialised containment solutions for high-value biologics, advanced therapies and sensitive drug formulations. These applications require high levels of product integrity, compatibility, stability and performance throughout the product life cycle.

By combining packaging design, materials science and pharmaceutical expertise, the company aims to develop solutions capable of supporting emerging drug-delivery requirements and next-generation therapies.

Commenting on the launch, Kairus Dadachanji, Managing Director, Kaisha Pharma, said, “Our previous experience was a defining chapter in our professional journey. Our vision is to create a truly global company that combines entrepreneurial agility, technical excellence and an unwavering commitment to customer success.”

Advanced Manufacturing and Inspection Capabilities

Kaisha Pharma’s manufacturing complex will cover more than 300,000 sq. ft. and feature integrated, state-of-the-art production lines. The facility will be equipped with sophisticated camera-based inspection systems and laboratories incorporating advanced analytical and testing equipment.

These capabilities will be supported by established manufacturing processes and an experienced workforce, with the objective of delivering consistent product quality across every production batch.

The company will also benefit from the capabilities of other businesses within the Dadachanji Group. This integrated ecosystem is intended to provide pharmaceutical companies with solutions spanning primary packaging, automation, machinery, fill-finish support systems and related pharmaceutical services.

Building on a Legacy of Innovation

The founders previously introduced syringe manufacturing in India when domestic production remained technically challenging. They were also among the early global developers of Ready-to-Use cartridge technology.

Kaisha Pharma plans to build on this experience through upgraded manufacturing technologies, stronger process controls and deeper scientific expertise. Its new generation of products is being developed to offer improved performance, reliability and consistency for pharmaceutical applications.

Rishad Dadachanji said, “Over the years, we have earned the trust of customers, partners and colleagues throughout the pharmaceutical industry. Kaisha Pharma builds upon that foundation while embracing the opportunities of a rapidly evolving global market. We are excited about the future and the value we can create for customers around the world.”

To strengthen its international presence, Kaisha Pharma is establishing a business development office in Europe. The office will serve as a regional hub for customer engagement, technical collaboration and market development, enabling the company to respond more quickly to evolving customer requirements.

With the next generation of leadership actively involved, Kaisha Pharma is combining decades of industry experience with new technology, operational agility and a long-term global outlook. Through continued investment in manufacturing, research and product development, the company aims to help advance the future of pharmaceutical packaging and drug-containment solutions.